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Abstract. Diabetic Retinopathy (DR) is one of the microvascular com-
plications of Diabetes Mellitus, which remains as one of the leading causes
of blindness worldwide. Computational models based on Convolutional
Neural Networks represent the state of the art for the automatic de-
tection of DR using eye fundus images. Most of the current work ad-
dress this problem as a binary classification task. However, including the
grade estimation and quantification of predictions uncertainty can poten-
tially increase the robustness of the model. In this paper, a hybrid Deep
Learning-Gaussian process method for DR diagnosis and uncertainty
quantification is presented. This method combines the representational
power of deep learning, with the ability to generalize from small datasets
of Gaussian process models. The results show that uncertainty quantifi-
cation in the predictions improves the interpretability of the method as
a diagnostic support tool. The source code to replicate the experiments is
publicly available at https://github.com/stoledoc/DLGP-DR-Diagnosis
Keywords: Deep Learning · Diabetic Retinopathy · Gaussian Process
· Uncertainty Quantification
1 Introduction
Diabetic Retinopathy (DR) is a consequence of Diabetes Mellitus that manifests
itself in the alteration of vascular tissue. When an alteration in the correct blood
supply occurs, lesions such as microaneurysms, hemorrhages and exudates ap-
pear [19]. These lesions can be identified in eye fundus images, one of the fastest
and least invasive methods for DR diagnosing. Although early detection and
monitoring are crucial to prevent progression and loss of vision [18], in devel-
oping countries approximately 40% of patients are not diagnosed due to lack of
access to the medical equipment and specialist, which puts patients of produc-
tive age at risk of visual impairment [19,22]. Therefore, to facilitate access to
rapid diagnosis and speed up the work of professionals, many efforts have been
made in the development of machine learning models focused on the analysis of
eye fundus images for automatic DR detection.
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For medical image analysis, deep Convolutional Neural Networks represent
the state of the art. These methods work by means of filters that go through the
image and exploit the natural structure of the data, being able to detect increas-
ingly complex patterns. However, the success of these deep learning models de-
pends on the availability of very large volumes of data, and this is not always the
case for medical image datasets. For instance, one of the largest public-available
image dataset for DR detection is EyePACS [5], which has 35126 samples for
training. For this reason, training a deep learning model for this problem from
scratch is not always feasible [9]. Instead, fine-tuning of pretrained models is
preferred, as it allows the models to refine a general knowledge for an specific
tasks. However, the number of specific sample images is not always enough to
make a tuning that produces good final performances [9].
Classical machine learning methods such as Gaussian Processes (GP), on the
other hand, were originally designed to work well with small data sets [6]. They
have different advantages over deep neural network models, as lower number
of parameters to train, convex optimization, modularity in model design, the
possibility to involve domain knowledge, and in the case of Bayesian approaches,
they allow the calculation of prediction uncertainty [20]. The latter would be
useful in medical applications, as it gives to the final user an indication of the
quality of the prediction [11].
This work presents and evaluates a hybrid deep learning-Gaussian process
model for the diagnosis of DR, and prediction uncertainty quantification. Taking
advantage of the representational power of deep learning, features were extracted
using an Inception-V3 model, fine-tuned with EyePACS dataset. With these
features we proceed to train a GP regression for DR grading.
Our framework shows that:
1. The performance of the proposed hybrid model trained as a regressor for the
DR grade, allows it to improve binary classification results when compared
with the single deep learning approach.
2. Gaussian processes can improve the performance of deep learning methods
by leveraging their ability to learn good image representations, when applied
for small datasets analysis.
3. The integration of GP endows the method with the ability to quantify the
uncertainty in the predictions. This improves the usability of the method as
a diagnostic support tool. Furthermore the experimental results show that
the predictions uncertainty is higher for false negatives and false positives
than for true positives and true negatives respectively. This is a high valued
skill in computational medical applications.
The paper is organized as follows: Section 2 presents a brief review of the
previous work related to the diagnosis and calculation of uncertainty of the of
DR automatic classification. Section 3 introduce the theoretical framework for
the experiments, which will be described in Section 4. Finally, in Section 5 the
discussion of the results and conclusions are presented.
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2 Related Work
Many approaches have been proposed for the DR binary detection, most of
them based in deep neural networks [14]. Some of them combine deep models
with metric learning techniques, as in [23], where an Inception-V3 is trained and
embedded into siamese-like blocks. The final DR binary or grade prediction is
given by a fully-connected layer. In [7], a customized deep convolutional neural
network to extract features is presented. The features and multiple metadata
related to the original fundus image are used to trained a gradient boosting
classifier to perform the DR prediction. In [12] an Inception-V3 model is once
again fine-tuned using a private set of eye fundus images, but not with binary
labels, but with five DR grade labels. The results are reported using a subset
of the Messidor-2 dataset [1,4]. This makes performance comparison impossible
with many other results, including those presented in this paper. Better results
were reported by Gulshan et al. in [8], where an ensemble of ten Inception-
V3 models, pretrained on ImageNet, are fine-tuned on a non-public eye fundus
image dataset. The final classification is calculated as the linear average over
the predictions of the ensemble. Results on Messidor-2 were reported, with a
remarkable 99% AUC score. In [17], Voets et al. attempted to reproduce the
results presented in [8], but it was not possible since the original study used non-
public datasets for training. However, Voets et al. published the source code and
models, and details on training procedure and hyperparameters are published in
[17] and [10].
Regarding the estimation of predictive uncertainty, the first work in this
matter in DR detection models was proposed in [11], where bayesian inference
is used for uncertainty quantification in binary classification of DR. Another
approach is presented in [13], where stochastic batch normalization is used to
calculate the uncertainty of the prediction of a model for DR level intervals
estimation. In the work presented in [15], a dataset with multiple labels given
by different doctors for each patient is used, which allows the calculation of
uncertainty to predict professional disagreement in a patient diagnosis.
In relation to convolutional neural networks uncertainty estimation using
GP, some work has been done specially outside the DR automatic detection
context, as in [21], where a framework is developed to estimate uncertainty in
any pretrained standard neural network, by modelling the prediction residuals
with a GP. This framework was applied to the IMDB dataset, for age estimation
based in face images. Also in [3], a GP on the top of a neural networks is end-to-
end trained, which makes the model much more robust to adversarial examples.
This model was used for classification in the MNIST and CIFAR-10 datasets.
To our knowledge, this is the first work that implements a GP to quantify
the uncertainty of a model predictions of DR diagnosis.
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3 Deep Learning Gaussian Process For Diabetic
Retinopathy Diagnosis (DLGP-DR)
The overall strategy of the proposed Deep Learning Gaussian Process For Dia-
betic Retinopathy grade estimation (DLGP-DR) method comprises three phases,
and is shown in Fig. 1. The first phase is a pre-processing stage, described in [17],
which is applied to all eye fundus image datasets used in this work. This pre-
processing eliminates the very dark images where the circular region of interest
is not identified, eliminates the excess of black margin, and resizes the images
to 299×299 pixels. The second phase is a feature extraction. An Inception-V3
model, trained with ImageNet and fine-tuned with EyePACS dataset is used as
feature extractor. Each sample is then represented by a 2048-dimensional vec-
tor. The third and final task is the DR diagnosis, which is performed by a GP
regressor.
Fig. 1. Proposed DLGP-DR model. Fine-tuned Inception-V3 is used as feature extrac-
tor. The extracted features are then used to train a Gaussian process.
3.1 Feature extraction - Inception-V3
Many previous works have used deep learning models for the diagnostic of DR.
Recently, Voets et al. [17] attempted to replicate the results published in [8], by
fine-tuning an assembly of ten pretrained Inception-V3 networks. While Voets
et al. were not able to achieve the same results reported in [8], most of the
implementation details, as well as the specific partitioning for the training and
test sets are publicly accessible, and were used in this study in the fine tuning
of an Inception-V3 model. Once trained, the feature extraction is achieved by
defining the global average pooling layer of the network as the output of the
model, and use it to predict all the images in the datasets. Thus, each image
will be represented by 2048 features which are used to train and evaluate the
GP model.
3.2 Gaussian Processes
Gaussian processes are a Bayesian machine learning regression approach that
are able to produce, in addition to the predictions, a value of uncertainty about
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them [6]. The method requires as input a covariance given by a kernel matrix.
The kernel matrix would be the gram matrix computed over the training set with
a Radial Basis Function (RBF). This RBF kernel depends on two parameters
which will be learned during the training process. We performed a Gaussian pro-
cess regression, where the labels are the five grades of retinopathy present in the
EyePACS dataset. From the prior, the GP calculates the probability distribution
of all the functions that fit the data, adjusting the prior from the evidence, and
optimizing the kernel parameters. Predictions are obtained by marginalizing the
final learned Gaussian distribution, which in turn yields another normal distri-
bution, whose mean is the value of the prediction, and its standard deviation
gives a measure of the uncertainty of the prediction. Thus, an optimized met-
ric (attached to a RBF similarity measure) is learned from the data, used to
estimate the DR grade.
This GP can be adapted to do binary classification. One simple way to do this
is defining a linear threshold in the prediction regression results. The standard
way however, consist in training a GP with binary labels and filtering the out-
put of the regression by a sigmoid function. This results in a Gaussian Process
Classifier (GPC). In any case, the predictions of a GPC are not longer subject
to a normal distribution, and the uncertainty can not be measured. Therefore,
the GPC will not take part in this study.
4 Experimental evaluation
4.1 Datasets
Experiments were performed with two eye fundus image datasets: EyePACS
and Messidor-2. EyePACS comes with labels for five grades of DR: grade 0
means no DR, 1, 2, and 3 means non-proliferative mild, moderate and severe
DR, while grade 4 means proliferative DR. For the binary classification task,
according to the International Clinical Diabetic Retinopathy Scale [2], grades 0
and 1 corresponds to non-referable DR, while grades 2, 3, and 4 correspond to
referable DR. In order to achieve comparable results with [17], we took the same
EyePACS partition used for training and testing (see Table 1). This partition
was constructed only to ensure that the proportion of healthy and sick examples
in training and testing was the same as that reported in [8]. EyePACS train
set is used for training and validation of the Inception-V3 model. Then, the
feature extraction described in Section 3 is applied. The extracted features are
used for training the DLGP-DR model. The evaluation is performed on the
EyePACS test set and on the Messidor-2, which is a standard dataset used to
compare performance results in DR diagnosis task. Datasets details are described
in Table 1 and in Table 2.
4.2 Experimental Setup
Fine-tuning was made to an Inception-V3 network, pretrained on ImageNet and
available in Keras [16]. The model was trained for binary DR classification task.
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Table 1. Details of Messidor-2 dataset used for testing. Class 0 correspond to non-
referable cases.
Class Test Samples
0 1368
1 380
Table 2. Details of the subset and final partition of the EyePACS dataset used for
training and testing. This is the same partition used in [17]. Grades 0 and 1 correspond
to non-referable patients, while grades 2, 3, and 4 correspond to referable cases.
Grade Train Samples Test Samples
0 37209 7407
1 3479 689
2 12873 0
3 2046 0
4 1220 694
The data augmentation configuration for horizontal reflection, brightness, satu-
ration, hue, and contrast changes, is described in [10], and it is the same used in
[17] and in [8]. The top layer of the Inception-V3 model is removed and replaced
by two dense layers of 2048 and 1 neurons. BinaryCrossentropy was used as loss
function and RMSprop as optimizer, with a learning rate of 10−6 and a decay
of 4× 10−5. The performance of the model is validated by measuring the AUC
in a validation set consisting of 20% of the training set.
Once the model is trained, the average pooling layer from the Inception-
V3 model is then used as output for feature extraction. The extracted features
from the Inception-V3 are normalized and used to train a GP regressor over the
five DR grade labels, it means, to perform the DR grading task. Therefore, the
output of the DLGP-DR is a continuous number indicating the DR grade.
Two baselines were defined to compare the DLGP-DR performance. Results
reported by Voets es al. [17] constitute the first baseline of this study. The second
baseline is an extension of the Inception-V3 model with two dense layers trained
on the same feature test as the Gaussian process, which is called as NN-model
hereafter.
4.3 EyePACS results
DLGP-DR is evaluated in the EyePACS test partition. The results are bina-
rized using a threshold of 1.5 (which is coherent with referable DR detection),
and compared with baselines in Table 3. In addition, although uncertainty es-
timation is not used to define or modify the prediction, DLGP-DR uncertainty
is analysed for false positives (FP), false negatives (FN), true positives (TP)
and true negatives (TN). As mentioned before, referable diabetic retinopathy is
defined as the presence of moderate, severe and proliferative DR. So, the false
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negatives are calculated as the patients that belong to grade 4 but are classified
as grades 0 and 1. The false positives are calculated as the patients belonging
to grades 0 and 1 but classified in grade 4. The results are shown in Fig. 2 and
Fig. 3.
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Fig. 2. Standard deviation for samples
predicted as negative (non-referable) in-
stances by DLGP-DR. FN: false nega-
tives, TN: true negatives.
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Fig. 3. Standard deviation for samples
predicted as positive (referable) instances
by DLGP-DR. FP: false positives, TP:
true positives.
4.4 Messidor-2 results
For Messidor-2 dataset, the predictions given by DLGP-DR are binarized using
athe same threshold of 1.5 used for EyePACS. Based on the results of the uncer-
tainty measured in the EyePACS test dataset, those samples predicted negative
for which the standard deviation was higher than 0.84, were changed to positive.
The results are reported and compared with the baselines in the Table 4.
Table 3. Comparison performance of DLGP-DR for binary classification in EyePACS
test partition used in [17]. As it is not the standard EyePACS test set, comparison is
not feasible with other similar studies.
Description Sensitivity Specificity AUC
Voets 2019 [17] 0.906 0.847 0.951
NN-model 0.9207 0.85 0.9551
DLGP-DR 0.9323 0.9173 0.9769
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Table 4. Comparison performance of DLGP-DR for binary classification in Messidor-2.
Referenced results from [17] were directly extracted from the respective documents.
Description Sensitivity Specificity AUC
Voets 2019 [17] 0.818 0.712 0.853
NN-model 0.7368 0.8581 0.8753
DLGP-DR 0.7237 0.8625 0.8787
4.5 Discussion
Results reported in Table 3 shows that DLGP-DR outperforms specificity and
AUC score of the NN-model and outperforms all the metrics reported by Voets
et al. [17]. As observed in Table 4, DLGP-DR outperforms both baselines for
specificity and AUC scores. Although Gulshan et al. have reported 0.99 for AUC
score in Messidor-2 [8], as Voets et al. comments in [17], the gap in the results
may be due to the fact that the training in that study was made with other
publicly available images and with a different gradation made by ophthalmolo-
gists. Overall, this shows that the global performance of the DLGP-DR exceeds
that of a neural network-based classifier. In addition, in Fig. 2 and Fig. 3 the
box-plot shows that the standard deviation is higher for false positives and false
negatives. This means, that the DLGP-DR model has bigger uncertainties for
wrong classified patients than for well classified. which provides the user a tool
to identify wrong predictions. This behavior is especially visible for false nega-
tives, which is the most dangerous mistake in medical applications, because a ill
patient can leave out without a needed treatment.
5 Conclusions
In this study we took a deep learning model fine-tuned on the EyePACS dataset
as feature extractor. The final task of DR classification and grading was carried
out by means of a Gaussian process. For DR binary classification, the proposed
DLGP-DR model reached better results than the original deep learning model.
We also showed that a fine DR grade classification improve the binary classifi-
cation performance of the original model.
Also, the DLGP-DR enables an uncertainty analysis. This analysis showed
that the model could allow the identification of both, false negatives and false
positives. The former are important due to the high cost of classifying a patient
as healthy when it is not, and the later because they increase the costs of health
care. The comparison between the Gaussian process and a neural network clas-
sifier for DR grades, showed once again that Gaussian processes are better tools
for the analysis of medical images, for which datasets are usually far small to be
analyzed entirely with deep learning techniques.
Overall, we demonstrate that the integration of deep learning and classical
machine learning techniques is highly feasible in applications with small datasets,
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taking advantage of the representational power of deep learning and the theo-
retical robustness of classical methods.
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